Clinical Epidemiology Overview

Principles

Definition

Clinical epidemiology is an academic field and methodological approach that applies principles and methods of epidemiology to address questions relevant to clinical practice and patient care. It investigates the determinants, diagnosis, prognosis, treatment, and prevention of disease in human populations encountered within clinical settings, bridging population-level understanding with individual patient management. Its significance lies in generating evidence to inform clinical decision-making, improve patient outcomes, and advance medical knowledge by systematically studying the occurrence and outcomes of disease in clinical populations.

Ontological type

Methodological Approaches

Impact on Clinical Practice

Core Concepts

Key developments

Key Figures

Foundations of Causal Methods era

Donald B. Rubin [1] is an influential author whose work in this era connects to Harvard University [3] and Princeton University [4]. In 1974 Rubin advanced the Estimating causal effects of treatments in randomized and nonrandomized studies [6], a key step toward rigorous causal inference across trial and observational designs in this era. William B. Kannel [2] is associated with Harvard University [3] and The University of Texas Southwestern Medical Center [5] in this period. His contributions include the Framingham study's general cardiovascular risk profile [7], a multivariate analysis of the risk of coronary heart disease in Framingham [8], and the Epidemiologic Assessment of the Role of Blood Pressure in Stroke [9], collectively shaping long-term cohort design and risk modeling central to this era.

Surveillance and Outcomes Standardization era

Robert F. Breiman [1] is associated with Johns Hopkins University [3] and Baylor College of Medicine [4] during the Surveillance and Outcomes Standardization era. His key contributions include Community‐Acquired Pneumonia in Adults: Guidelines for Management [7], Emergence of Drug-Resistant Pneumococcal Infections in the United States [8], and The Spread of Multiply Resistant Streptococcus pneumoniae at a Day Care Center in Ohio [9], which advanced standardization and surveillance by informing infection-control practices. Allison McGeer [2] is associated with Yale University [5] and University of Toronto [6] during this era. Her contributions include Decreased Susceptibility of<i>Streptococcus pneumoniae</i>to Fluoroquinolones in Canada [10] and Mortality from invasive pneumococcal pneumonia in the era of antibiotic resistance, 1995-1997 [11], underscoring the impact of antibiotic resistance on outcomes and the need for standardized surveillance.

Standardized Global Data Integration era

Peter C Gøtzsche [1] is a leading figure in clinical epidemiology during the Standardized Global Data Integration era, with affiliations at the University of Bristol [3] and Brown University [4]. His key contributions include The Cochrane Collaboration's tool for assessing risk of bias in randomised trials [7], The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) Statement: Guidelines for Reporting Observational Studies [8], and Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) [9], which together advanced standardized reporting and critical appraisal essential for harmonizing data across multicenter datasets in this era. David Moher [2] is a leading figure in clinical epidemiology during the same era with affiliations at Stanford University [5] and Johns Hopkins University [6]. His key contributions include The Cochrane Collaboration's tool for assessing risk of bias in randomised trials [7] and Recommendations for examining and interpreting funnel plot asymmetry in meta-analyses of randomised controlled trials [10], which advanced methodological rigor and interpretation guidelines that underpin transparent synthesis in standardized data integration.